General Information of the Compound
Compound ID
CP0378506
Compound Name
3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
    Show/Hide
Synonyms
1313725-88-0
1H-1,2,3-Triazolo(4,5-b)pyrazine, 1-((1S)-1-imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-
2A2DA6857R
4-{1-[(1S)-1-{imidazo[1,2-a]pyri
AKOS030526403
AS-35250
AZD-6094
AZD6094
BDBM50023342
CHEMBL3334567
DB12048
EX-A845
FT-0700162
GTPL9918
HY-15959
J-690125
KB-333895
SCHEMBL12489208
Savolitinib
Savolitinib [INN]
Savolitinib [USAN:INN]
UNII-2A2DA6857R
Volitinib(Savolitinib)
ZINC149738712
compound 28 [PMID: 25148209]
    Show/Hide
Structure
Formula
C17H15N9
Molecular Weight
345.37
Canonical SMILES
C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(nc12)-c1cnn(C)c1
    Show/Hide
InChI
InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1
    Show/Hide
InChIKey
XYDNMOZJKOGZLS-NSHDSACASA-N
CAS
1313725-88-0
Physicochemical Property
logP
1.8788
Rotatable Bonds
3
Heavy Atom Count
26
Polar Areas
91.61
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
9
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 68289010
ChEMBL ID
CHEMBL3334567
DrugBank ID
DB12048
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000450 NCI-H441 Homo sapiens (Human)  1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 5 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000281 NCI-H1993 Homo sapiens (Human)  1
1
GI50 = 8317.64 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Savolitinib )
Drug Name Savolitinib
Company AstraZeneca Wilmington, DE
Indication
Renal cell carcinoma
Phase 3
Solid tumour/cancer
Phase 2
Target(s)
Proto-oncogene c-Met (MET)
Inhibitor